Natural History of Human Epidermal Growth Factor Receptor 2–Amplified and Human Epidermal Growth Factor Receptor 2 Wild-Type Refractory Metastatic Colorectal Cancer in US Clinical Practice

The molecular heterogeneity of metastatic colorectal cancer (mCRC) presents a therapeutic challenge, with few trials focused on patients with human epidermal growth factor receptor 2 amplification (HER2-Amp). Our limited understanding of real-world patterns and outcomes by HER2 status of treatment-r...

Descripción completa

Detalles Bibliográficos
Autores principales: Schröder, Carsten, Gower-Page, Craig, Reyes-Rivera, Irmarie, Patel, Arisha, Price, Richard, Sen, Shiraj, Davies, Jessica, Castellanos, Emily, Snider, Jeremy, Bai, Xiaobo, Fisher, Virginia, Mhatre, Shivani K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2022
Materias:
ORIGINAL REPORTS
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8955081/
https://www.ncbi.nlm.nih.gov/pubmed/35297649
http://dx.doi.org/10.1200/CCI.21.00133

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8955081/
https://www.ncbi.nlm.nih.gov/pubmed/35297649
http://dx.doi.org/10.1200/CCI.21.00133

Ejemplares similares